Table of Content

1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 11
1.3 SCOPE OF THE STUDY 12
1.3.1 MARKETS COVERED 12
FIGURE 1 US OUTPATIENT SURGICAL PROCEDURES MARKET 12
1.3.2 YEARS CONSIDERED FOR THE STUDY 12
1.4 STAKEHOLDERS 13
1.5 SUMMARY OF CHANGES 13
1.6 LIMITATIONS 13
2 RESEARCH METHODOLOGY 14
2.1 RESEARCH DATA 14
FIGURE 2 RESEARCH DESIGN 14
2.1.1 SECONDARY DATA 14
2.1.1.1 Key data from secondary sources 15
2.1.2 PRIMARY DATA 16
2.1.2.1 Key data from primary sources 16
2.1.2.2 Key industry insights 17
2.2 MARKET ESTIMATION 17
FIGURE 3 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE US SURGICAL PROCEDURES MARKET (2022–2027) 18
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 19
FIGURE 4 MARKET DATA TRIANGULATION METHODOLOGY 19
2.4 ASSUMPTIONS FOR THE STUDY 20
2.5 METHODOLOGY-RELATED LIMITATIONS 20
3 EXECUTIVE SUMMARY 21
FIGURE 5 US SURGICAL PROCEDURES MARKET, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 21
FIGURE 6 GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 22
FIGURE 7 CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 22
FIGURE 8 DENTAL SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 23
FIGURE 9 COSMETIC SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 23
FIGURE 10 UROLOGIC SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 24
FIGURE 11 OPHTHALMIC SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 24
FIGURE 12 ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 25
FIGURE 13 ENT SURGICAL PROCEDURES MARKET, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 25
FIGURE 14 OBSTETRIC/ GYNECOLOGIC SURGICAL PROCEDURES MARKET, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 26
FIGURE 15 US SURGICAL PROCEDURES MARKET, BY CHANNEL,
2022 VS. 2027 (THOUSAND PROCEDURES) 26
4 PREMIUM INSIGHTS 28
4.1 US SURGICAL PROCEDURES MARKET OVERVIEW 28
FIGURE 16 GROWTH IN GERIATRIC POPULATION AND RISE IN CHRONIC DISEASES TO DRIVE MARKET GROWTH 28
4.2 US SURGICAL PROCEDURES MARKET, BY TYPE 29
FIGURE 17 DENTAL SURGICAL PROCEDURES SEGMENT TO HOLD THE LARGEST SHARE OF THE US SURGICAL PROCEDURES MARKET IN 2021 29
5 MARKET OVERVIEW 30
5.1 INTRODUCTION 30
5.2 MARKET DYNAMICS 30
FIGURE 18 US SURGICAL PROCEDURES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 30
5.2.1 DRIVERS 31
5.2.1.1 Growing prevalence of cancer requiring surgical treatment 31
FIGURE 19 US: CANCER CASES, BY TYPE, 2020–2040 (THOUSANDS) 31
FIGURE 20 US: NEW CANCER CASES, 2012–2022 (MILLION INDIVIDUALS) 32
5.2.1.2 Growth in geriatric population and rise in chronic diseases 32
FIGURE 21 US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1995–2030 (MILLION) 33
5.2.1.3 Technological advancements in surgical procedures 34
TABLE 1 US: RISE IN SURGICAL PROCEDURES 34
FIGURE 22 US: R&D INVESTMENTS IN MEDICAL TECHNOLOGY, 2013-2018 (MILLION) 35
5.2.2 RESTRAINTS 35
5.2.2.1 Shortage of surgeons 35
5.2.3 OPPORTUNITIES 36
5.2.3.1 Increasing adoption of outpatient surgeries 36
5.2.4 CHALLENGES 36
5.2.4.1 Surgical errors 36
5.2.4.2 Complications associated with surgical procedures 38
TABLE 2 COMPLICATIONS ASSOCIATED WITH SURGICAL PROCEDURES 38
?
6 INDUSTRY INSIGHTS 40
6.1 INTRODUCTION 40
6.2 INDUSTRY TRENDS 40
6.2.1 MINIMALLY INVASIVE SURGERY 40
6.2.2 INCREASING ADOPTION OF ADVANCED ROBOTICS IN ASCS 41
6.3 REIMBURSEMENT SCENARIO 42
TABLE 3 LIST OF SURGICAL PROCEDURE CODES 43
6.4 IMPACT OF COVID-19 ON THE US SURGICAL PROCEDURES MARKET 44
6.5 TECHNOLOGY ANALYSIS 45
7 US SURGICAL PROCEDURES MARKET, BY TYPE 46
7.1 INTRODUCTION 47
TABLE 4 US: SURGICAL PROCEDURES MARKET, BY TYPE, 2020–2027 (THOUSAND) 47
7.2 DENTAL SURGICAL PROCEDURES 48
7.2.1 INCREASING PREVALENCE OF ORAL DISEASES AND RISING AWARENESS OF DENTAL CARE DRIVE THE GROWTH OF DENTAL SURGICAL PROCEDURES 48
TABLE 5 US: DENTAL SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND) 48
7.3 ORTHOPEDIC SURGICAL PROCEDURES 49
7.3.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED ORTHOPEDIC DEVICES WILL INCREASE THE NUMBER OF ORTHOPEDIC SURGICAL PROCEDURES 49
TABLE 6 US: ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE,
2020-2027 (THOUSAND) 50
7.4 GASTROINTESTINAL SURGICAL PROCEDURES 50
7.4.1 THE INCREASING NUMBER OF GASTROINTESTINAL CANCER CASES IS DRIVING GROWTH IN THIS SEGMENT 50
FIGURE 23 US: STOMACH CANCER INCIDENCE, 2020–2040 (THOUSANDS) 51
TABLE 7 US: GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE,
2020-2027 (THOUSAND) 52
7.5 OPHTHALMIC SURGICAL PROCEDURES 52
7.5.1 RISING PREVALENCE OF GLAUCOMA, CATARACT, AND DIABETIC RETINOPATHY DRIVE DEMAND FOR OPHTHALMIC SURGICAL TREATMENT IN THE US 52
TABLE 8 US: OPHTHALMIC SURGICAL PROCEDURES, BY TYPE,
2020-2027 (THOUSAND) 53
7.6 CARDIOVASCULAR SURGICAL PROCEDURES 53
7.6.1 HEART DISEASE IS THE LEADING CAUSE OF DEATH IN THE US 53
TABLE 9 US: NUMBER OF CASES OF CARDIOVASCULAR DISEASES,
2015-2035 (MILLION) 54
FIGURE 24 US: MORTALITY RATE OF CARDIOVASCULAR DISEASES, BY TYPE, 2018 55
TABLE 10 US: CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE,
2020-2027 (THOUSAND) 55
7.7 OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES 56
7.7.1 INCREASING INCIDENCE OF GYNECOLOGICAL DISEASES DRIVES MARKET GROWTH 56
TABLE 11 US: OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES, BY TYPE,
2020–2027 (THOUSAND) 57
7.8 ENT SURGICAL PROCEDURES 57
7.8.1 RISING DISPOSABLE INCOME AND INCREASING AFFORDABILITY ARE MAJOR REASONS FOR THE GROWTH OF ENT SURGICAL PROCEDURES 57
TABLE 12 US: ENT SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 58
7.9 COSMETIC SURGICAL PROCEDURES 58
7.9.1 ADVENT OF MINIMALLY INVASIVE SURGICAL PROCEDURES BOOSTS
THE ADOPTION OF COSMETIC SURGERIES 58
TABLE 13 US: COSMETIC SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 60
7.10 UROLOGIC SURGICAL PROCEDURES 60
7.10.1 INCREASING INCIDENCE OF DIABETES AND HIGH BLOOD PRESSURE INCREASES THE RISK OF KIDNEY DISEASES 60
TABLE 14 US: UROLOGIC SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 61
7.11 OTHER SURGICAL PROCEDURES 61
TABLE 15 US: NERVOUS SYSTEM SURGICAL PROCEDURES, BY TYPE,
2020–2027 (THOUSAND) 62
TABLE 16 US: ENDOCRINE SYSTEM SURGICAL PROCEDURES, BY TYPE,
2020–2027 (THOUSAND) 62
TABLE 17 US: INTEGUMENTARY SYSTEM SURGICAL PROCEDURES, BY TYPE,
2020–2027 (THOUSAND) 63
8 US SURGICAL PROCEDURES MARKET, BY CHANNEL 64
8.1 INTRODUCTION 65
TABLE 18 US SURGICAL PROCEDURES MARKET, BY CHANNEL,
2020–2027 (THOUSAND) 65
8.2 PHYSICIAN OFFICES 65
8.2.1 TECHNOLOGICAL ADVANCES MAKING OFFICE-BASED SURGERY MORE FEASIBLE DRIVE THE MARKET GROWTH 65
8.3 HOSPITALS 66
TABLE 19 US: NUMBER OF REGISTERED HOSPITALS, BY NUMBER OF BEDS (2019) 66
TABLE 20 US SURGICAL PROCEDURES MARKET FOR HOSPITALS, BY TYPE,
2020–2027 (THOUSAND) 67
8.3.1 INPATIENT SURGERIES 67
8.3.1.1 Increasing incidences of cardiovascular, neurological, and intestinal disorders are driving growth for this market 67
FIGURE 25 US NATIONAL INPATIENT STAYS, 2016–2018 68
8.3.2 OUTPATIENT SURGERIES 68
8.3.2.1 Convenience and lower cost are major advantages of outpatient surgeries 68
8.4 AMBULATORY SURGERY CENTERS 69
8.4.1 LOWER COSTS AND SHORTER PATIENT STAYS PROPEL THE GROWTH OF
THIS SEGMENT 69

9 APPENDIX 71
9.1 DISCUSSION GUIDE 71
9.2 KNOWLEDGE STORE: MARKETSANDMARKETS? SUBSCRIPTION PORTAL 76
9.3 RELATED REPORTS 78
9.4 AUTHOR DETAILS 79